Patent · US Active

Erythroid cells comprising phenylalanine ammonia lyase

US10557119B2 · kind B2 · utility

4Cited by
37References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2019
Grant dateFeb 11, 2020
Priority date
Expiry dateMay 10, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.